Analysis of antiviral regimen in outpatients with chronic hepatitis B
10.13699/j.cnki.1001-6821.2017.22.025
- VernacularTitle:慢性乙型病毒性肝炎患者抗病毒药物使用情况分析
- Author:
Ying JIA
1
;
Lu LI
;
Xiao-Guang LI
;
Jing-Jin LIANG
;
Zhong-Hua DENG
;
Fei LIN
;
Yuan-Bo SU
;
Bi-Ying ZHANG
;
Jing CHEN
;
Wei WANG
;
Yong-Feng KANG
;
Jie XU
Author Information
1. 北京大学第三医院感染疾病科
- Keywords:
chronic hepatitis B;
antiviral angents;
survey
- From:
The Chinese Journal of Clinical Pharmacology
2017;33(22):2308-2310
- CountryChina
- Language:Chinese
-
Abstract:
Objective To study the antiviral regimen among outpatients with chronic hepatitis B in general hospital.Methods Outpatients diagnosed with chronic hepatitis B between January 2014 and January 2016 were included.All of them needed antiviral therapy.Retrospective study was done to their antiviral agents with cross-section analysis.Results A total of 83.9％ outpatients with chronic hepatitis B were accepting antiviral therapy and most of them used nucleos(t)ide analogs.There were 78.0％ of them chosed single or combined nucleos (t) ide analogs,16.4％ chosed interferon α plus nucleos(t) ide analogs,5.6％ chosed single interferon α.The most frequently used nucleos(t) ide analogs were Entecavir and then adefovir dipivoxil.Conclusion Nucleos (t)ide analogs were frequently used in outpatients with chronic hepatitis B and Entecavir ranked first place.Interferon α should be enhanced.
